Altair International Corp. financial data

Symbol
ATAO on OTC
Industry
Surgical & Medical Instruments & Apparatus
Location
322 North Shore Drive, Building 1 B, Suite 200, Pittsburgh, PA
State of incorporation
NV
Fiscal year end
March 31
Latest financial report
10-Q - Q2 2024 - Aug 15, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 5.16 % -75.4%
Debt-to-equity -105 % +16.6%
Return On Equity 108 % -88.1%
Return On Assets -1.98K % +42.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 32M shares +29.5%
Common Stock, Shares, Outstanding 32M shares +5.75%
Entity Public Float 8.02M USD 0%
Common Stock, Value, Issued 32K USD +29.5%

Income Statement

Label TTM Value / Value Unit Change %
General and Administrative Expense 98.5K USD +15.2%
Operating Income (Loss) -175K USD +50.9%
Net Income (Loss) Attributable to Parent -271K USD +84.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 7.21K USD -74.9%
Assets, Current 11.4K USD -65.1%
Assets 11.4K USD -65.1%
Accounts Payable, Current 5K USD -13.2%
Employee-related Liabilities, Current 62K USD +933%
Accrued Liabilities, Current 0 USD -100%
Liabilities, Current 218K USD -37.8%
Liabilities 218K USD -37.8%
Retained Earnings (Accumulated Deficit) -17.6M USD -1.57%
Stockholders' Equity Attributable to Parent -206K USD +35%
Liabilities and Equity 11.4K USD -65.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -23.5K USD +6.64%
Net Cash Provided by (Used in) Financing Activities 26.4K USD +5.6%
Common Stock, Shares Authorized 5B shares 0%
Common Stock, Shares, Issued 32M shares +5.75%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 2.91K USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 7.21K USD -74.9%
Deferred Tax Assets, Valuation Allowance 3.68M USD +2.34%
Deferred Tax Assets, Operating Loss Carryforwards 3.68M USD +2.34%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Additional Paid in Capital 17.3M USD +2.21%
Preferred Stock, Shares Outstanding 0 shares
Interest Expense 99.3K USD -40.2%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%